Question 1

Am I eligible for this trial based on my previous treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) clinical trial (NCT07419295). Contact the study team or your healthcare provider for specific answers.

Question 2

How does Sac-TMT compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) clinical trial (NCT07419295). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of Sac-TMT?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) clinical trial (NCT07419295). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatment and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) clinical trial (NCT07419295). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) clinical trial (NCT07419295). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there a chance I could receive a placebo instead of the actual treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) clinical trial (NCT07419295). Contact the study team or your healthcare provider for specific answers.

What this study is about